Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.

Front Pharmacol · 2023 · PMC9941545 · PMID 36825152

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Three mutations (e.g., K248M, R203M, and P168S) were highly significant out of 16 deleterious mutations found in the nucleocapsid.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.